Profile: Akorn, Inc. develops and markets branded & multi-source pharmaceutical products. As a specialty pharmaceutical company, we are focused on three major business segments including ophthalmology, hospitals and contract manufacturing. We offer products like vaccines, ophthalmics, hospital drugs, product highlights, DTPA, view basket & check out. With a full line of ophthalmic diagnostic, therapeutic and over-the-counter products, we market established brands like IC-Green, AK-Fluor, Fluress, Fluoracaine, Ful-Glo and Gentak. We supply the brand Myochrysine®, which is a cost-effective therapy used in the treatment of rheumatoid arthritis.

The company was founded in 1971, has revenues of USD 50-100 Million, has ~330 employees. NASDAQ:AKRX (SEC Filings)

FDA Registration Number: 1419498